Relation between botulinum toxin and nitric oxide donors in the treatment of chronic anal fissure

Medical Science Monitor

Volumn 11, Issue 2, 2005, Pages

  Madaliński, Mariusz ^a,c   Chodorowski, Zygmunt ^b  

^a St John Hospital   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c NONE   (Poland)

Author keywords

Anal fissure; Botulinum toxin; Nitric oxide; Sphincterotomy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETHANECHOL; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; DILTIAZEM; GLYCERYL TRINITRATE; INDORAMIN; ISOSORBIDE DINITRATE; NIFEDIPINE; NITRIC OXIDE DONOR;

ANUS FISSURE; ANUS SPHINCTER; DEFECATION; DIZZINESS; DOSE RESPONSE; FLUSHING; HEADACHE; HEALING; HUMAN; ISCHEMIA; MICROCIRCULATION; PATHOGENESIS; REVIEW; SIDE EFFECT; SMOOTH MUSCLE FIBER; SPHINCTEROTOMY; SYMPATHETIC TONE; SYNTHESIS; TISSUE PERFUSION; TREATMENT OUTCOME;

ANAL CANAL; BOTULINUM TOXIN TYPE A; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; FISSURE IN ANO; HUMANS; NITRIC OXIDE; NITRIC OXIDE DONORS; WOUND HEALING;

EID: 13844253488     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Schouten WR, Briel JAV, Auwerda JJA, DeGraaf EJR: Ischaemic nature of anal fissure. Br J Surg, 1996; 83: 63-65
2. Lund JN, Scholefield JH: Aetiology and treatment of anal fissure. Br J Surg, 1996; 83: 1335-44
3. Soybel DI: What causes anal fissure? Gastroenterology, 1996; 111: 1154-55
4. Gui D, Rossi S, Runfola M, Magalini S.C.: Review article: botulinum toxin in the therapy of gastrointestinal motility disorders. Aliment Pharmacol Ther, 2003; 18: 1-16
5. Utzig MJ, Kroesen AJ, Buhr HJ: Concepts in pathogenesis and treatment of chronic anal fissure - a review of the literature. Am J Gastroenterol, 2003; 98: 968-74
6. American Gastroenterological Association. American Gastroenterological Association medical position statement: Diagnosis and care of patients with anal fissure. Gastroenterology, 2003; 124: 233-34
7. Hasler WL: The expanding spectrum of clinical uses for botulinum toxin: healing of chronic anal fissures. Gastroenterology, 1999; 116: 221-23
8. st ed. Philadelphia: Lippincott Williams & Wilkins; 2002; 75-88
9. Munchau A, Bhatia KP. Uses of botulinum toxin injection in medicine today. BMJ, 2000; 320: 161-65
10. Madaliński M, Jagiełło K, Labon M et al: Botulinum toxin injection into only one point in the external anal sphincter: a modification of the treatment for chronic anal fissure. Endoscopy, 1999; 31: S63
11. Minguez M, Herreros B, Espi A et al: Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin. Gastroenterology, 2002; 123: 112-17
12. Jost WH, Schimrigk K: Botulinum toxin in therapy of anal fissure. Lancet, 1995; 345: 188-89
13. Jost WH: Influence of botulinum toxin injections on the sphincteric compound muscle action potential of the external anal sphincter. Dis Colon Rectum, 1997; 40: 995-96
14. Gui D, Cassetta E, Anastasio G et al: Botulinum toxin for chronic anal fissure. Lancet, 1994; 344: 1127-28
15. Maria G, Brisinda G, Bentivoglio AR et al: Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure. Ann Surg, 1998; 228: 664-69
16. Brisinda G, Maria G, Bentivoglio AR et al: A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med, 1999; 341: 65-69
17. Schafer A, Enck P, Furst G et al: Anatomy of the anal sphincters. Comparison of anal endosonography to magnetic resonance imaging. Dis Colon Rectum, 1994; 37: 777-81
18. Madaliński M: Nonsurgical treatment modalities for chronic anal fissure using botulinum toxin. Gastroenterology, 1999; 117: 516-17
19. Shaari ChM, Sanders I: Assessment of the biological activity of botulinum toxin. In: Jankovic J, Hallet M, editors. Therapy with botulinum toxin. New York: Dekker; 1994; 159-70
20. Simpson J, Lund JN, Thompson RJ et al: The use of glyceryl (GTN) in the treatment of chronic anal fissure in children. Med Sci Monit, 2003; 9(10): PII23-PII29
21. Griffin N, Zimmerman DD, Briel JW et al: Topical L-arginine gel lowers resting anal pressure: possible treatment for anal fissure. Dis Colon Rectum, 2002; 45: 1332-36
22. th United European Gastroenterology Week. 1999 Nov 15-17; Rome, Italy. Gut, 1999; 45(Suppl.V): A304
23. Madaliński M, Sławek J, Zbytek B et al: Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure. Hepato-Gastroenterology, 2001; 48: 977-79
24. Lysy J, Israelit-Yatzkan Y, Mima I et al: Combined botulinum toxin (BT) and isosorbide dinitrate (ID) is more effective than BT alone in patients with refractory anal fissure. Gastroenterology, 1999; 116: A1033
25. Lysy J, Israelit-Yatzkan Y, Sestiery-Ittah M et al: Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure. Gut, 2001; 48: 221-24
26. Brisinda G, Maria G, Sganga G et al: Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery, 2002; 131: 179-84
27. Pitt J, Craggs MM, Henry MM, Boulos PB: Alpha-1 adrenoceptor blockade: potential new treatment for anal fissures. Dis Colon Rectum, 2000; 43: 800-3
28. Carapeti EA, Kamm MA, Philips RKS: Topical diltiazem and betanechol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum, 2000; 43: 1359-62
29. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylocholine. Nature, 1980; 288: 373-76
30. Ignarro LJ, Buga GM, Wood KS et al: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA, 1987; 84: 9265-69
31. Bassenge E: Endothelial function in different organs. Prog Cardiovasc Dis, 1996; 39: 209-28
32. Perner A, Rask-Madsen J: Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders. Aliment Pharmacol Ther, 1999; 13: 135-44
33. Gibbons CP, Read NW: Anal hypertonia in fissures: cause or effect? Br J Surg, 1986; 73: 443-45
34. Madaliński M, Adrich Z, Kryszewski A: Nitric oxide donors and the potentiate effect of their action after botulinum toxin application for the treatment of chronic anal fissure. Pol Arch Med Wew, 2002; 107: 69-74
35. Jones OM, Brading AF, Mortensen NJ: Mechanism of action of botulinum toxin on the internal anal sphincter. Br J Surg, 2004; 91: 224-28
36. Galkina SI, Dormeneva EV, Bachschmid M et al: Endothelium-leukocyte interactions under the influence of the superoxide-nitrogen monoxide system. Med Sci Monit, 2004, 10(9): BR307-BR316
37. Esch T, Stefano GB: Proinflammation: A common denominator or initiator of different pathophysiological disease processes. Med Sci Monit, 2002, 8: HY1-HY9
38. Mariotti R, Bentivoglio M: Botulinum toxin induces nitric oxide synthase activity in motoneurons. Neurosci Lett, 1996; 219: 25-28
39. Brisinda G, Maria G, Bentivoglio AR, Albanese A: The role of botulinum toxin in gastrointestinal disorders, In: Brin MF, Hallett M, Jankovic J, editors. Scientific and therapeutic aspects of botulinum toxin. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2002, 269-85
40. Jiang JK, Chiu JH, Lin JK: Local somatothermal stimulation inhibits motility of the internal anal sphincter through nitrergic neural release of nitric oxide. Dis Colon Rectum, 2000; 43: 381-88
41. Chen Z, Zhang J, Stamler J: Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA, 2002; 99: 8306-11
42. Rosales RL, Arimura K, Takenaga S, Osame M: Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve, 1996; 19: 488-96
43. Thant ZS, Tan EK: Emegering therapeutic applications of botulinum toxin. Med Sci Monit, 2003; 9(2): RA40-RA48
44. Madaliński M, Slawek J, Duzynski W et al: Side effects of botulinum toxin injection for bening anal disorders. Eur J Gastroenterol Hepatol. 2002; 14: 853-56